首页 > 最新文献

Clinical eHealth最新文献

英文 中文
Exploring the metaverse hospital beyond your imagination 探索超出你想象的超宇宙医院
Pub Date : 2023-07-22 DOI: 10.1016/j.ceh.2023.07.004
Mengting Sun , Chunxue Bai , Dawei Yang
{"title":"Exploring the metaverse hospital beyond your imagination","authors":"Mengting Sun , Chunxue Bai , Dawei Yang","doi":"10.1016/j.ceh.2023.07.004","DOIUrl":"https://doi.org/10.1016/j.ceh.2023.07.004","url":null,"abstract":"","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"6 ","pages":"Pages 53-59"},"PeriodicalIF":0.0,"publicationDate":"2023-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49725932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact on mental health due to COVID-19 pandemic: A cross-sectional study in Bangladesh COVID-19大流行对心理健康的影响:孟加拉国的一项横断面研究
Pub Date : 2023-07-20 DOI: 10.1016/j.ceh.2023.07.002
Refat Khan Pathan , Munmun Biswas , Suraiya Yasmin , Mohammad Amaz Uddin , Anindya Das , Mayeen Uddin Khandaker , M.R.I. Faruque , Moniruzzaman Sarker

The government of Bangladesh has implemented the “Stay Home” policy following the WHO recommendation to resist the community transmission of Covid-19. As a result, the routine activities of all government, semi-government establishments, including educational institutions, are severely affected, and the country's economic growth becomes slowed down. To overcome such a situation, the relevant authorities have introduced the “Work from Home” policy for the employees and “Remote Education” for students. However, due to the persistence of multi-dimensional socio-economic problems, many employees and students face big challenges in performing their regular jobs while adopting such a policy. Consequently, enormous psychological anxiety has been developed for all people, including students, parents, employees, etc., and concurrently created severe changes in their behavior. This study aims to analyze the reasons for the behavioral changes of the employees, students, academic staff, and family members of different ages due to psychological anxiety, stress, or physical issues. A comprehensive online-based survey has been carried out on people working in various sectors in Bangladesh. A modified Apriori Algorithm has been used to sort out the associations between the causes and types of behavioral changes. Analyzed data revealed a massive human behavioral change in most participants. This finding indicates that the negligence of those significant human behavioral changes may cause a higher risk of creating psychological imbalance. Therefore, there is a need to have a solid understanding of the reasons for the behavioral changes and set up standard guidelines to maintain “Work from Home” in this Covid-19 situation to avoid psychological imbalance. Based on this study, some suggestions have been given for implementation by the government on an urgent basis.

根据世界卫生组织的建议,孟加拉国政府实施了“待在家里”政策,以阻止新冠肺炎的社区传播。因此,包括教育机构在内的所有政府、半政府机构的日常活动都受到严重影响,国家经济增长放缓。为了克服这种情况,有关部门为员工推出了“在家工作”政策,并为学生推出了“远程教育”。然而,由于多维社会经济问题的持续存在,许多员工和学生在采取这种政策的同时,在履行常规工作方面面临巨大挑战。因此,包括学生、家长、员工等在内的所有人都产生了巨大的心理焦虑,同时也造成了他们行为的严重变化。本研究旨在分析不同年龄的员工、学生、教职员工和家庭成员因心理焦虑、压力或身体问题而发生行为变化的原因。对孟加拉国各部门的工作人员进行了一项全面的在线调查。使用一种改进的Apriori算法来整理行为变化的原因和类型之间的关联。分析数据显示,大多数参与者的行为发生了巨大变化。这一发现表明,忽视这些重大的人类行为变化可能会导致更高的心理失衡风险。因此,有必要深入了解行为变化的原因,并制定标准指南,在这种新冠肺炎情况下保持“在家工作”,以避免心理失衡。基于这一研究,提出了一些建议,以供政府紧急实施。
{"title":"Impact on mental health due to COVID-19 pandemic: A cross-sectional study in Bangladesh","authors":"Refat Khan Pathan ,&nbsp;Munmun Biswas ,&nbsp;Suraiya Yasmin ,&nbsp;Mohammad Amaz Uddin ,&nbsp;Anindya Das ,&nbsp;Mayeen Uddin Khandaker ,&nbsp;M.R.I. Faruque ,&nbsp;Moniruzzaman Sarker","doi":"10.1016/j.ceh.2023.07.002","DOIUrl":"https://doi.org/10.1016/j.ceh.2023.07.002","url":null,"abstract":"<div><p>The government of Bangladesh has implemented the “Stay Home” policy following the WHO recommendation to resist the community transmission of Covid-19. As a result, the routine activities of all government, semi-government establishments, including educational institutions, are severely affected, and the country's economic growth becomes slowed down. To overcome such a situation, the relevant authorities have introduced the “Work from Home” policy for the employees and “Remote Education” for students. However, due to the persistence of multi-dimensional socio-economic problems, many employees and students face big challenges in performing their regular jobs while adopting such a policy. Consequently, enormous psychological anxiety has been developed for all people, including students, parents, employees, etc., and concurrently created severe changes in their behavior. This study aims to analyze the reasons for the behavioral changes of the employees, students, academic staff, and family members of different ages due to psychological anxiety, stress, or physical issues. A comprehensive online-based survey has been carried out on people working in various sectors in Bangladesh. A modified Apriori Algorithm has been used to sort out the associations between the causes and types of behavioral changes. Analyzed data revealed a massive human behavioral change in most participants. This finding indicates that the negligence of those significant human behavioral changes may cause a higher risk of creating psychological imbalance. Therefore, there is a need to have a solid understanding of the reasons for the behavioral changes and set up standard guidelines to maintain “Work from Home” in this Covid-19 situation to avoid psychological imbalance. Based on this study, some suggestions have been given for implementation by the government on an urgent basis.</p></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"6 ","pages":"Pages 42-52"},"PeriodicalIF":0.0,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49711849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Large volume whole lung lavage combined with granulocyte-macrophage colony-stimulating factor inhalation in the treatment of severe pulmonary alveolar proteinosis: A case report and literature review 大容量全肺灌洗联合粒细胞-巨噬细胞集落刺激因子吸入治疗重度肺泡蛋白沉积症1例并文献复习
Pub Date : 2023-07-07 DOI: 10.1016/j.ceh.2023.06.004
Wang Yun , Wu Xue-ling , Wang Qian-yu , Jiang Peng , Liao Jiang-rong

Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the accumulation of large amounts of phospholipid protein-like surfactant material in the alveolar spaces, leading to severe hypoxemia and respiratory failure. The disease has an insidious onset and is difficult to diagnose in the early stages. Its clinical manifestations primarily include progressive dyspnea and coughing. Currently, whole lung lavage (WLL) is the preferred and effective treatment for PAP, as it improves alveolar ventilation function. Granulocyte colony-stimulating factor is used clinically in the treatment of a variety of disease. Nebulized granulocyte–macrophage colony-stimulating factor (GM-CSF) has a certain therapeutic effect on PAP. Here, we report a case of PAP treated with WLL combined with nebulized GM-CSF, which achieved good therapeutic effects during a 4-year follow-up period, to enhance understanding of the disease.

肺泡蛋白沉积症(PAP)是一种罕见的肺部疾病,其特征是肺泡间隙积聚大量磷脂蛋白样表面活性剂物质,导致严重低氧血症和呼吸衰竭。这种疾病起病隐匿,早期难以诊断。其临床表现主要包括进行性呼吸困难和咳嗽。目前,全肺灌洗(WLL)是PAP的首选且有效的治疗方法,因为它可以改善肺泡通气功能。粒细胞集落刺激因子在临床上被用于治疗多种疾病。雾化粒细胞-巨噬细胞集落刺激因子(GM-CSF)对PAP有一定的治疗作用。在此,我们报告了一例PAP患者,WLL联合雾化GM-CSF治疗,在4年的随访期内取得了良好的治疗效果,以增强对该疾病的了解。
{"title":"Large volume whole lung lavage combined with granulocyte-macrophage colony-stimulating factor inhalation in the treatment of severe pulmonary alveolar proteinosis: A case report and literature review","authors":"Wang Yun ,&nbsp;Wu Xue-ling ,&nbsp;Wang Qian-yu ,&nbsp;Jiang Peng ,&nbsp;Liao Jiang-rong","doi":"10.1016/j.ceh.2023.06.004","DOIUrl":"https://doi.org/10.1016/j.ceh.2023.06.004","url":null,"abstract":"<div><p>Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the accumulation of large amounts of phospholipid protein-like surfactant material in the alveolar spaces, leading to severe hypoxemia and respiratory failure. The disease has an insidious onset and is difficult to diagnose in the early stages. Its clinical manifestations primarily include progressive dyspnea and coughing. Currently, whole lung lavage (WLL) is the preferred and effective treatment for PAP, as it improves alveolar ventilation function. Granulocyte colony-stimulating factor is used clinically in the treatment of a variety of disease. Nebulized granulocyte–macrophage colony-stimulating factor (GM-CSF) has a certain therapeutic effect on PAP. Here, we report a case of PAP treated with WLL combined with nebulized GM-CSF, which achieved good therapeutic effects during a 4-year follow-up period, to enhance understanding of the disease.</p></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"6 ","pages":"Pages 38-41"},"PeriodicalIF":0.0,"publicationDate":"2023-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49733828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A brief evaluation on mobile stroke Unit and mobile CT 移动脑卒中单元与移动CT的简要评价
Pub Date : 2023-06-30 DOI: 10.1016/j.ceh.2023.06.005
Yujie Zheng , Jumin Li , Mengli Ma , Dawei Yang
{"title":"A brief evaluation on mobile stroke Unit and mobile CT","authors":"Yujie Zheng ,&nbsp;Jumin Li ,&nbsp;Mengli Ma ,&nbsp;Dawei Yang","doi":"10.1016/j.ceh.2023.06.005","DOIUrl":"https://doi.org/10.1016/j.ceh.2023.06.005","url":null,"abstract":"","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"6 ","pages":"Pages 36-37"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49711882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metaverse: Freezing the time 时空:冻结时间
Pub Date : 2023-06-09 DOI: 10.1016/j.ceh.2023.06.002
Pengxin Qian , Dawei Yang , Chunxue Bai

Considering the poor efficacy of drug treatment, the non-drug therapy is vital for Alzheimer’s disease (AD). As an ultimate form of Internet, Metaverse will become mainstream industry in the future. This thesis reviews advances in non-drug therapy (Reminiscence Therapy, Music Therapy, Horticultural Therapy, Animal-Assisted Therapy) of Alzheimer’s disease and introduce the Metaverse and its application in field of medicine. Finally, the author thinks Metaverse will be used to store human’s memories and proposed Metaverse Therapy for AD patients as one of the non-drug treatment in the future.

考虑到药物治疗效果不佳,非药物治疗对阿尔茨海默病至关重要。作为互联网的终极形态,元宇宙将成为未来的主流产业。本文综述了阿尔茨海默病的非药物治疗(回忆疗法、音乐疗法、园艺疗法、动物辅助疗法)的进展,并介绍了元宇宙及其在医学领域的应用。最后,作者认为Metaverse将用于存储人类的记忆,并提出Metaverse疗法作为未来AD患者的非药物治疗之一。
{"title":"Metaverse: Freezing the time","authors":"Pengxin Qian ,&nbsp;Dawei Yang ,&nbsp;Chunxue Bai","doi":"10.1016/j.ceh.2023.06.002","DOIUrl":"https://doi.org/10.1016/j.ceh.2023.06.002","url":null,"abstract":"<div><p>Considering the poor efficacy of drug treatment, the non-drug therapy is vital for Alzheimer’s disease (AD). As an ultimate form of Internet, Metaverse will become mainstream industry in the future. This thesis reviews advances in non-drug therapy (Reminiscence Therapy, Music Therapy, Horticultural Therapy, Animal-Assisted Therapy) of Alzheimer’s disease and introduce the Metaverse and its application in field of medicine. Finally, the author thinks Metaverse will be used to store human’s memories and proposed Metaverse Therapy for AD patients as one of the non-drug treatment in the future.</p></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"6 ","pages":"Pages 29-35"},"PeriodicalIF":0.0,"publicationDate":"2023-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49725936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune aging and pulmonary diseases 免疫老化和肺部疾病
Pub Date : 2023-06-08 DOI: 10.1016/j.ceh.2023.06.001
Liang Guo , Yu Xu , Xi Liu , Yu Yang , Zhi Xu , Li Bai

Pulmonary immune system, constituted with innate immune and adaptive immune, defenses against pathogens, eliminates senescent cells, and maintains pulmonary physiological homeostasis. The physiological changes in immune system were known as “immune senescence” with increasing age, characterized by increased susceptibility to infection and cancer, reduced response to vaccines, and accompanied by chronic low-grade inflammation. T lymphocytes, B lymphocytes and NK cell immune senescence are the main phenotype of immune senescence. T lymphocytes senescence characterized by immune deficiency and inflammation, caused by thymus degeneration, mitochondrial dysfunction, genetic and epigenetic changes, protein homeostasis imbalance with increasing age. B lymphocytes senescence phenotype is mainly manifested with the decrease of B lymphocytes quantity and quality, and the deficiency in transformation and recombination with increasing age. Meanwhile, with increasing age, NK cells showed changes in cell function, number of cells, and proportion of NK cell subsets. In recent years, a large number of studies have found that the above immune aging changes with increasing age promoted occurrence and development of pulmonary diseases, especially chronic obstructive pulmonary disease (COPD), lung cancer. Even more, there were new therapeutic approach that target to “immunosenescence” have been developed clinically, such as immunotherapy for patients with COPD and lung cancer. However, there are some confusion about the regulatory mechanism of immune senescence in lung diseases and clinical real world. Therefore, this article reviews immune aging, mechanisms of immune aging in the development and progression of lung diseases, mainly included COPD, lung cancer, as well as current immunotherapy targeting to immune senescence, problems, and future directions.

肺部免疫系统由先天免疫和适应性免疫组成,防御病原体,消除衰老细胞,维持肺部生理稳态。随着年龄的增长,免疫系统的生理变化被称为“免疫衰老”,其特征是对感染和癌症的易感性增加,对疫苗的反应降低,并伴有慢性低度炎症。T淋巴细胞、B淋巴细胞和NK细胞免疫衰老是免疫衰老的主要表型。T淋巴细胞衰老以免疫缺陷和炎症为特征,由胸腺退化、线粒体功能障碍、遗传和表观遗传学变化、蛋白质稳态失衡引起。B淋巴细胞衰老表型主要表现为随着年龄的增长,B淋巴细胞数量和质量下降,转化和重组缺乏。同时,随着年龄的增长,NK细胞的细胞功能、细胞数量和NK细胞亚群比例都发生了变化。近年来,大量研究发现,上述免疫衰老随着年龄的增长而变化,促进了肺部疾病的发生和发展,尤其是慢性阻塞性肺病(COPD)、肺癌癌症。更重要的是,临床上已经开发出了针对“免疫衰老”的新治疗方法,例如针对COPD和癌症患者的免疫疗法。然而,在肺部疾病和临床现实世界中,对免疫衰老的调节机制存在一些困惑。因此,本文综述了免疫衰老、免疫衰老在肺部疾病发展和进展中的机制,主要包括慢阻肺、肺癌癌症,以及目前针对免疫衰老的免疫疗法、存在的问题和未来的发展方向。
{"title":"Immune aging and pulmonary diseases","authors":"Liang Guo ,&nbsp;Yu Xu ,&nbsp;Xi Liu ,&nbsp;Yu Yang ,&nbsp;Zhi Xu ,&nbsp;Li Bai","doi":"10.1016/j.ceh.2023.06.001","DOIUrl":"https://doi.org/10.1016/j.ceh.2023.06.001","url":null,"abstract":"<div><p>Pulmonary immune system, constituted with innate immune and adaptive immune, defenses against pathogens, eliminates senescent cells, and maintains pulmonary physiological homeostasis. The physiological changes in immune system were known as “immune senescence” with increasing age, characterized by increased susceptibility to infection and cancer, reduced response to vaccines, and accompanied by chronic low-grade inflammation. T lymphocytes, B lymphocytes and NK cell immune senescence are the main phenotype of immune senescence. T lymphocytes senescence characterized by immune deficiency and inflammation, caused by thymus degeneration, mitochondrial dysfunction, genetic and epigenetic changes, protein homeostasis imbalance with increasing age. B lymphocytes senescence phenotype is mainly manifested with the decrease of B lymphocytes quantity and quality, and the deficiency in transformation and recombination with increasing age. Meanwhile, with increasing age, NK cells showed changes in cell function, number of cells, and proportion of NK cell subsets. In recent years, a large number of studies have found that the above immune aging changes with increasing age promoted occurrence and development of pulmonary diseases, especially chronic obstructive pulmonary disease (COPD), lung cancer. Even more, there were new therapeutic approach that target to “immunosenescence” have been developed clinically, such as immunotherapy for patients with COPD and lung cancer. However, there are some confusion about the regulatory mechanism of immune senescence in lung diseases and clinical real world. Therefore, this article reviews immune aging, mechanisms of immune aging in the development and progression of lung diseases, mainly included COPD, lung cancer, as well as current immunotherapy targeting to immune senescence, problems, and future directions.</p></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"6 ","pages":"Pages 24-28"},"PeriodicalIF":0.0,"publicationDate":"2023-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49725934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A machine-learning approach for prediction of hospital mortality in cancer-related sepsis 预测癌症相关败血症住院死亡率的机器学习方法
Pub Date : 2023-06-08 DOI: 10.1016/j.ceh.2023.06.003
YiRan He , YuJing Liu , YiMei Liu , HongYu He , WenJun Liu , DanLei Huang , ZhunYong Gu , MinJie Ju

Objective

To develop a machine learning model to predict hospital mortality and identify risk factors in cancer-related sepsis patients.

Method

We obtained data from the Medical Information Mart for Intensive Care (MIMIC)-IV critical care data set, which included patients who diagnosed with cancer and fulfilled the definition of sepsis between 2008 and 2019. The data set was randomly split into a training set and a validation set. The dataset was imputed using the K-Nearest Neighbor (KNN) imputation model. An advanced machine learning model called CatBoost was established and then assessed by SHAP value.

Results

A total of 5081 patients were included in the final analysis. The cancer-related sepsis patients had a lower hospital survival (13.8% vs. 25.3%, P < 0.001) than non-cancer-related patients.

For cancer-related sepsis patients, ensemble learning algorithms were superior to others with better accuracy and larger AUC, such as CatBoost (AUC: 0.828), LightGBM (AUC: 0.818), and Random Forest Classifier (AUC: 0.803). An evaluation of the performance suggested that the CatBoost model with the most powerful discrimination to predict hospital mortality, outperformed other models with a sensitivity of 76% and a specificity of 74%. The best cutoff was 0.223 for the CatBoost model. In addition, CatBoost also outperformed other severity scores such as SAPS-II (AUC: 0.725) and SOFA (AUC: 0.682). Urine output and the minimum BUN level on admission were the most important features for the hospital mortality prediction of cancer-related sepsis, while the patients’ age and the urine output on admission for non-cancer-related patients.

Conclusion

For cancer-related sepsis patients, CatBoost model was a better prediction model. It was easy for clinicians to access by use of common clinical vital signs or laboratory examination parameters, which provides convenience for them to evaluate patient’s condition and make follow-up treatments.

目的建立一种机器学习模型,用于预测癌症相关脓毒症患者的住院死亡率和识别危险因素。方法我们从重症监护医疗信息集市(MIMIC)-IV重症监护数据集获得数据,其中包括2008年至2019年间诊断为癌症并符合败血症定义的患者。数据集被随机分为训练集和验证集。使用K-最近邻(KNN)插补模型对数据集进行插补。建立了一个名为CatBoost的高级机器学习模型,并通过SHAP值进行了评估。结果纳入最终分析的患者共5081例。与非癌症相关的患者相比,癌症相关的败血症患者的住院生存率较低(13.8%对25.3%,P<;0.001)。对于癌症相关败血症患者,集合学习算法优于其他具有更好准确性和更大AUC的算法,如CatBoost(AUC:0.8828)、LightGBM(AUC=0.818)和随机森林分类器(AUC:8.83),优于其他模型,灵敏度为76%,特异性为74%。CatBoost模型的最佳截止值为0.223。此外,CatBoost还优于其他严重程度评分,如SAPS-II(AUC:0.725)和SOFA(AUC:6.682)。入院时的尿量和最低BUN水平是预测癌症相关脓毒症住院死亡率的最重要特征,而患者的年龄和非癌症相关患者入院时的尿液量。结论对于癌症相关性脓毒症患者,CatBoost模型是一种较好的预测模型。临床医生通过使用常见的临床生命体征或实验室检查参数很容易获得,这为他们评估患者的病情和进行后续治疗提供了便利。
{"title":"A machine-learning approach for prediction of hospital mortality in cancer-related sepsis","authors":"YiRan He ,&nbsp;YuJing Liu ,&nbsp;YiMei Liu ,&nbsp;HongYu He ,&nbsp;WenJun Liu ,&nbsp;DanLei Huang ,&nbsp;ZhunYong Gu ,&nbsp;MinJie Ju","doi":"10.1016/j.ceh.2023.06.003","DOIUrl":"https://doi.org/10.1016/j.ceh.2023.06.003","url":null,"abstract":"<div><h3>Objective</h3><p>To develop a machine learning model to predict hospital mortality and identify risk factors in cancer-related sepsis patients<u>.</u></p></div><div><h3>Method</h3><p>We obtained data from the Medical Information Mart for Intensive Care (MIMIC)-IV critical care data set, which included patients who diagnosed with cancer and fulfilled the definition of sepsis between 2008 and 2019. The data set was randomly split into a training set and a validation set. The dataset was imputed using the K-Nearest Neighbor (KNN) imputation model. An advanced machine learning model called CatBoost was established and then assessed by SHAP value.</p></div><div><h3>Results</h3><p>A total of 5081 patients were included in the final analysis. The cancer-related sepsis patients had a lower hospital survival (13.8% vs. 25.3%, P &lt; 0.001) than non-cancer-related patients.</p><p>For cancer-related sepsis patients, ensemble learning algorithms were superior to others with better accuracy and larger AUC, such as CatBoost (AUC: 0.828), LightGBM (AUC: 0.818), and Random Forest Classifier (AUC: 0.803). An evaluation of the performance suggested that the CatBoost model with the most powerful discrimination to predict hospital mortality, outperformed other models with a sensitivity of 76% and a specificity of 74%. The best cutoff was 0.223 for the CatBoost model. In addition, CatBoost also outperformed other severity scores such as SAPS-II (AUC: 0.725) and SOFA (AUC: 0.682). Urine output and the minimum BUN level on admission were the most important features for the hospital mortality prediction of cancer-related sepsis, while the patients’ age and the urine output on admission for non-cancer-related patients.</p></div><div><h3>Conclusion</h3><p>For cancer-related sepsis patients, CatBoost model was a better prediction model. It was easy for clinicians to access by use of common clinical vital signs or laboratory examination parameters, which provides convenience for them to evaluate patient’s condition and make follow-up treatments.</p></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"6 ","pages":"Pages 17-23"},"PeriodicalIF":0.0,"publicationDate":"2023-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49711881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Access barriers to care for patients with silent cerebrovascular disease (SCD) in rural China: A cross-sectional questionnaire-based study 中国农村无症状脑血管病患者获得护理的障碍:一项基于横断面问卷的研究
Pub Date : 2023-06-02 DOI: 10.1016/j.ceh.2023.05.002
Xiaoyu Wang , Tongtong Wu , Beini Fei , Xin Li , Yanmin Tang , Yanan Zheng , Yusheng Jia , Jing Ding , Min Hu

Background

Timely diagnosis and treatment of silent cerebrovascular disease (SCD) are critical for future cerebrovascular disease prevention, whereas asymptomatic specificity of SCD can lead to a lack of reasonable healthcare utilization. In China, access barriers to care for SCD patients is rarely studied. This study aimed to estimate the access barriers to care for SCD patients in rural China and explored associated factors.

Methods

We constructed a demand-side questionnaire using the six-dimensional model of access barriers to care, and collected survey data in Guizhou province, China. Data from SCD patients were collected including demographics, health status, and self-perceived access barriers to care. Linear regression was used to estimate the association between access barriers to care and self-reported health status.

Results

A total of 162 SCD patients were included in the analysis. The questionnaire’s measures are adoptable with reliability (Cronbach’s α = 0.86) and validity (KMO = 0.774, Bartlett’s test p-value < 0.05). The average score of access barriers to care for SCD patients in Guizhou was 13.41 (SD = 4.08). Average scores vary across the six dimensions, and affordability has the highest score of 3.07 (SD = 0.13), indicating the highest level of access barriers in terms of affordability. The lowest scored dimension is acceptability which score is 1.62 (SD = 0.33), indicating SCD patients had a relatively high willingness in receiving healthcare services. Regression outcome reported that self-reported worse health status was significantly associated with higher level of access barriers (p-value < 0.01).

Conclusion

This study estimated overall and by-dimension access barriers to care for patients with SCD in rural China and investigated the association between health status and access barriers to care. The varied level of different dimensions of access barriers to care suggested that interventions designed to facilitate healthcare utilization should be specific and target those SCD patients who are in poorer health status and have difficulty affording healthcare expenses.

背景无症状脑血管病(SCD)的及时诊断和治疗对未来的脑血管疾病预防至关重要,而无症状特异性SCD可能导致缺乏合理的医疗利用。在中国,很少研究SCD患者获得护理的障碍。本研究旨在评估中国农村SCD患者获得护理的障碍,并探讨相关因素。方法采用获得护理障碍的六维模型构建需求侧问卷,并收集贵州省的调查数据。收集SCD患者的数据,包括人口统计、健康状况和自我感知的获得护理的障碍。使用线性回归来估计获得护理的障碍与自我报告的健康状况之间的关联。结果纳入分析的SCD患者共162例。调查问卷具有信度(Cronbachα=0.86)和有效性(KMO=0.774,Bartlett检验p值<;0.05)。贵州SCD患者获得护理障碍的平均得分为13.41(SD=4.08)。六个维度的平均得分各不相同,负担能力得分最高,为3.07(SD=0.13),表明在可负担性方面存在最高水平的准入障碍。得分最低的维度是可接受性,得分为1.62(SD=0.33),表明SCD患者接受医疗服务的意愿相对较高。回归结果显示,自我报告的较差健康状况与较高的获得障碍水平显著相关(p值<;0.01)。获得护理的不同层面的不同程度的障碍表明,旨在促进医疗保健利用的干预措施应该是特定的,并针对那些健康状况较差、难以负担医疗保健费用的SCD患者。
{"title":"Access barriers to care for patients with silent cerebrovascular disease (SCD) in rural China: A cross-sectional questionnaire-based study","authors":"Xiaoyu Wang ,&nbsp;Tongtong Wu ,&nbsp;Beini Fei ,&nbsp;Xin Li ,&nbsp;Yanmin Tang ,&nbsp;Yanan Zheng ,&nbsp;Yusheng Jia ,&nbsp;Jing Ding ,&nbsp;Min Hu","doi":"10.1016/j.ceh.2023.05.002","DOIUrl":"https://doi.org/10.1016/j.ceh.2023.05.002","url":null,"abstract":"<div><h3>Background</h3><p>Timely diagnosis and treatment of silent cerebrovascular disease (SCD) are critical for future cerebrovascular disease prevention, whereas asymptomatic specificity of SCD can lead to a lack of reasonable healthcare utilization. In China, access barriers to care for SCD patients is rarely studied. This study aimed to estimate the access barriers to care for SCD patients in rural China and explored associated factors.</p></div><div><h3>Methods</h3><p>We constructed a demand-side questionnaire using the six-dimensional model of access barriers to care, and collected survey data in Guizhou province, China. Data from SCD patients were collected including demographics, health status, and self-perceived access barriers to care. Linear regression was used to estimate the association between access barriers to care and self-reported health status.</p></div><div><h3>Results</h3><p>A total of 162 SCD patients were included in the analysis. The questionnaire’s measures are adoptable with reliability (Cronbach’s α = 0.86) and validity (KMO = 0.774, Bartlett’s test p-value &lt; 0.05). The average score of access barriers to care for SCD patients in Guizhou was 13.41 (SD = 4.08). Average scores vary across the six dimensions, and affordability has the highest score of 3.07 (SD = 0.13), indicating the highest level of access barriers in terms of affordability. The lowest scored dimension is acceptability which score is 1.62 (SD = 0.33), indicating SCD patients had a relatively high willingness in receiving healthcare services. Regression outcome reported that self-reported worse health status was significantly associated with higher level of access barriers (p-value &lt; 0.01).</p></div><div><h3>Conclusion</h3><p>This study estimated overall and by-dimension access barriers to care for patients with SCD in rural China and investigated the association between health status and access barriers to care. The varied level of different dimensions of access barriers to care suggested that interventions designed to facilitate healthcare utilization should be specific and target those SCD patients who are in poorer health status and have difficulty affording healthcare expenses.</p></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"6 ","pages":"Pages 10-16"},"PeriodicalIF":0.0,"publicationDate":"2023-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49711657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient-individual 3D-printing of drugs within a machine-learning-assisted closed-loop medication management – Design and first results of a feasibility study 在机器学习辅助闭环药物管理中对患者进行药物的个人3d打印-可行性研究的设计和初步结果
Pub Date : 2023-05-25 DOI: 10.1016/j.ceh.2023.05.001
Claudia Langebrake , Karl Gottfried , Adrin Dadkhah , Jan Eggert , Tobias Gutowski , Moritz Rosch , Nils Schönbeck , Christopher Gundler , Sylvia Nürnberg , Frank Ückert , Michael Baehr

3D-printing of medicines is an innovative manufacturing method that is characterised by a high degree of digitalisation and automation and enables patient-specific care. Its integration into routine healthcare processes currently fails mainly due to the requirements of a digital environment. Our hospital was the first hospital in Europe to introduce a fully comprehensive patient record in 2011 and to digitalise and automate the drug supply process.

The aim of our study is to evaluate the integration of a machine-learning assisted 3D printing of medicines into the already existing, fully digital medication process of the hospital (closed-loop medication management, CLMM). Here, the design of this feasibility study and first results of subprojects are presented.

First, a suitable and clinically relevant active ingredient (levodopa/carbidopa) was identified in a multi-step approach by an interdisciplinary panel of experts using defined evaluation criteria, taking into account galenic, clinical and machine learning aspects. In the next step, a galenic formulation using a suitable printing technology for manufacturing a drug according to pharmaceutical quality criteria in different dosages is to be developed and to be evaluated for compliance with quality criteria according to the European Pharmacopoeia. Furthermore, an IT concept was developed and adapted to the hospital's current IT infrastructure. Likewise, a machine learning algorithm is to be developed to determine the optimal dose for each individual patient using data from smart wearable devices. For this purpose, a clinical trial was set up as a proof-of-principle study for the use of wearables to detect and grade clinical symptoms from Parkinson’s Disease. Finally, the process is to be connected to the digital medication process of the hospital taking into account regulatory requirements.

Thus, this interdisciplinary feasibility study will provide important insights into the possibilities of integrating patient-specific 3D printing of medicines into everyday clinical practice in the hospital.

药物的3D打印是一种创新的制造方法,其特点是高度数字化和自动化,能够实现针对患者的护理。目前,它与常规医疗流程的集成失败,主要是由于数字环境的要求。我们的医院是欧洲第一家在2011年引入全面患者记录并实现药品供应流程数字化和自动化的医院。我们研究的目的是评估机器学习辅助的药物3D打印与医院现有的全数字化药物流程(闭环药物管理,CLMM)的集成。在此,介绍了本可行性研究的设计和子项目的初步结果。首先,一个跨学科专家小组使用定义的评估标准,在考虑到半乳糖、临床和机器学习方面的情况下,通过多步骤方法确定了一种合适的临床相关活性成分(左旋多巴/卡比多巴)。在下一步中,将开发一种使用合适的印刷技术的半乳糖制剂,用于根据不同剂量的药物质量标准生产药物,并根据《欧洲药典》评估其是否符合质量标准。此外,还开发了一个IT概念,并根据医院当前的IT基础设施进行了调整。同样,将开发一种机器学习算法,使用智能可穿戴设备的数据来确定每个患者的最佳剂量。为此,建立了一项临床试验,作为使用可穿戴设备检测和分级帕金森病临床症状的原理验证研究。最后,考虑到监管要求,该流程将与医院的数字用药流程相连接。因此,这项跨学科的可行性研究将为将针对患者的药物3D打印融入医院日常临床实践的可能性提供重要见解。
{"title":"Patient-individual 3D-printing of drugs within a machine-learning-assisted closed-loop medication management – Design and first results of a feasibility study","authors":"Claudia Langebrake ,&nbsp;Karl Gottfried ,&nbsp;Adrin Dadkhah ,&nbsp;Jan Eggert ,&nbsp;Tobias Gutowski ,&nbsp;Moritz Rosch ,&nbsp;Nils Schönbeck ,&nbsp;Christopher Gundler ,&nbsp;Sylvia Nürnberg ,&nbsp;Frank Ückert ,&nbsp;Michael Baehr","doi":"10.1016/j.ceh.2023.05.001","DOIUrl":"https://doi.org/10.1016/j.ceh.2023.05.001","url":null,"abstract":"<div><p>3D-printing of medicines is an innovative manufacturing method that is characterised by a high degree of digitalisation and automation and enables patient-specific care. Its integration into routine healthcare processes currently fails mainly due to the requirements of a digital environment. Our hospital was the first hospital in Europe to introduce a fully comprehensive patient record in 2011 and to digitalise and automate the drug supply process.</p><p>The aim of our study is to evaluate the integration of a machine-learning assisted 3D printing of medicines into the already existing, fully digital medication process of the hospital (closed-loop medication management, CLMM). Here, the design of this feasibility study and first results of subprojects are presented.</p><p>First, a suitable and clinically relevant active ingredient (levodopa/carbidopa) was identified in a multi-step approach by an interdisciplinary panel of experts using defined evaluation criteria, taking into account galenic, clinical and machine learning aspects. In the next step, a galenic formulation using a suitable printing technology for manufacturing a drug according to pharmaceutical quality criteria in different dosages is to be developed and to be evaluated for compliance with quality criteria according to the European Pharmacopoeia. Furthermore, an IT concept was developed and adapted to the hospital's current IT infrastructure. Likewise, a machine learning algorithm is to be developed to determine the optimal dose for each individual patient using data from smart wearable devices. For this purpose, a clinical trial was set up as a proof-of-principle study for the use of wearables to detect and grade clinical symptoms from Parkinson’s Disease. Finally, the process is to be connected to the digital medication process of the hospital taking into account regulatory requirements.</p><p>Thus, this interdisciplinary feasibility study will provide important insights into the possibilities of integrating patient-specific 3D printing of medicines into everyday clinical practice in the hospital.</p></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"6 ","pages":"Pages 3-9"},"PeriodicalIF":0.0,"publicationDate":"2023-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49711927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections 社论:预防COVID-19症状性感染的灭活疫苗
Pub Date : 2023-05-03 DOI: 10.1016/j.ceh.2023.04.001
Yifan Chen

Omicron variants of SARS-CoV-2 have been become the dominant variant family among more than 100 countries and regions around the world. There are still limited data on how inactivated COVID-19 vaccines prevent Omicron-related symptomatic infection, transmission, hospital admission, and death3. Recently, Dawei Yang et al. published a paper in the to explore the effect of inactivated COVID-19 vaccines on Omicron from the perspective of real-world observation data.

严重急性呼吸系统综合征冠状病毒2型的奥密克戎变异株已成为全球100多个国家和地区的主要变异株家族。关于新冠肺炎灭活疫苗如何预防奥密克戎相关症状感染、传播、住院和死亡的数据仍然有限3。近日,杨大伟等在《》杂志上发表论文,从真实世界的观察数据出发,探讨新冠肺炎灭活疫苗对奥密克戎的影响。
{"title":"Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections","authors":"Yifan Chen","doi":"10.1016/j.ceh.2023.04.001","DOIUrl":"https://doi.org/10.1016/j.ceh.2023.04.001","url":null,"abstract":"<div><p>Omicron variants of SARS-CoV-2 have been become the dominant variant family among more than 100 countries and regions around the world. There are still limited data on how inactivated COVID-19 vaccines prevent Omicron-related symptomatic infection, transmission, hospital admission, and death3. Recently, Dawei Yang et al. published a paper in the to explore the effect of inactivated COVID-19 vaccines on Omicron from the perspective of real-world observation data.</p></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"6 ","pages":"Pages 1-2"},"PeriodicalIF":0.0,"publicationDate":"2023-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49711745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical eHealth
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1